SEC Form 4 · accession 0001093557-18-000033
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrance H Gregg
Officer — Executive Chairman · Director
Period of report
Mar 8, 2018
Accepted (ET)
Mar 12, 2018 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 8, 2018 | A | 47,087 | $0.001 | A | 531,646 | D | |
| Common Stock | holding | — | — | — | 11,461 | I | by IRA | |
| Common StockF3 | holding | — | — | — | 20,882 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Included in this number are 47,087 unvested restricted stock units which were granted on March 8, 2018 and shall vest through March 8, 2021.
- F3Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.